Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Kemal, Özyurt"'
Autor:
Samet KARAHAN, Kemal ÖZYURT
Publikováno v:
Ahi Evran Medical Journal, Vol 7, Iss 2, Pp 183-189 (2023)
Purpose: Psoriatic arthritis (PsA) is an inflammatory musculoskeletal disease. The exact causes of PsA have not been identified. ABO and Rh blood groups continue to be an area of interest for various diseases. In this study, we aimed to evaluate whet
Externí odkaz:
https://doaj.org/article/57b5f9473da8486281f094d8171a7a11
Publikováno v:
Turkderm Turkish Archives of Dermatology and Venereology, Vol 56, Iss 3, Pp 109-112 (2022)
Background and Design: Systemic retinoids are commonly used medications in dermatology and indicated in various skin disorders such as acne vulgaris and psoriasis. Data about the risk of Coronavirus disease-2019 (COVID-19) in patients using systemic
Externí odkaz:
https://doaj.org/article/723b8d12455740068696a4ae8591d11b
Autor:
Huzeyfe Kulu, Mustafa Atasoy, Kemal Özyurt, Marcus Maurer, Atıl Avcı, Muhammet Reşat Akkuş, Ragıp Ertaş
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
IntroductionThe COVID-19 pandemic dramatically disrupts health care for patients with chronic diseases including chronic spontaneous urticaria (CSU). As of now, it is unknown if the effects of the pandemic in CSU are different than in other chronic d
Externí odkaz:
https://doaj.org/article/2235f84cafb444e08816173bda9b54e6
Autor:
Murat Türk, Ragıp Ertaş, Ümit Murat Şahiner, Pavel Kolkhir, Bülent Enis Şekerel, Özge Soyer, Atıl Avcı, Mustafa Atasoy, Kemal Özyurt, Yekta Türk, Engin Zeydan, Marcus Maurer
Publikováno v:
International Archives of Allergy and Immunology. :1-12
Introduction: The use of predictors of response to a specific treatment in patients with chronic spontaneous urticaria (CSU) can improve disease management, help prevent unnecessary healthcare costs, and save time. In this study, we aimed to identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17fc6b2364a16a6a3904efc5bac59a06
https://doi.org/10.1159/000528395
https://doi.org/10.1159/000528395
Autor:
Abdullah Demirbaş, Kemal Özyurt, Ömer Faruk Elmas, Mahmut Sami Metin, Mustafa Atasoy, Ümit Türsen, Asuman Kilitci, Torello Lotti
Publikováno v:
Cyprus Journal of Medical Sciences. 6:7-13
BACKGROUND/AIMS: Many studies have focused on the epidemiological features of adult and childhood psoriasis. However, only a few studies have been conducted to demonstrate the clinical and demographic characteristics of pediatric psoriasis in Turkey.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d658feba0d3ba7b2c589e03864ec53fa
https://doi.org/10.4274/cjms.2021.2021-38
https://doi.org/10.4274/cjms.2021.2021-38
Publikováno v:
Journal of the Turkish Academy of Dermatology. 16:46-49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df0d12180d77f7f2b5ec4edc7eae6482
https://doi.org/10.4274/jtad.galenos.2022.36036
https://doi.org/10.4274/jtad.galenos.2022.36036
Publikováno v:
Turkiye Klinikleri Journal of Dermatology. 32:62-68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7699f915f1883eca86a13f0aa8cbdfcb
https://doi.org/10.5336/dermato.2021-86898
https://doi.org/10.5336/dermato.2021-86898
Publikováno v:
F1000Research, Vol 6 (2017)
Recently, a few case reports and clinical studies have been published that explore the association of Behçet’s Disease (BD) and vitiligo, with conflicting results. Genetic and immunological properties of BD and presence of autoantibodies support a
Externí odkaz:
https://doaj.org/article/c3e84640e173486da28fe6c0b3d96a9d
Autor:
Muhammed Reşat Akkuş, Yılmaz Ulaş, Atıl Avcı, Mustafa Atasoy, Kemal Özyurt, Yücel Tekin, Ragıp Ertaş
Publikováno v:
Turkiye Klinikleri Journal of Dermatology. 31:49-52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23f3753ce93272b8b8c429ef87610516
https://doi.org/10.5336/dermato.2019-71356
https://doi.org/10.5336/dermato.2019-71356
Publikováno v:
Iranian Journal of Allergy, Asthma and Immunology, Vol 15, Iss 1 (2016)
Omalizumab is a recombinant humanized anti-Ig E monoclonal antibody used as the third line treatment of chronic spontaneous urticaria (CSU). We report four patients with severe antihistamine-resistant CSU, who developed angioedema, anaphylaxis and/or
Externí odkaz:
https://doaj.org/article/dcd706a185af439d8127d8e608262b67